Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: May 2024

MissionIRNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces Publication of Article on Emerging Candidate – Sigyn Therapy(TM)

Posted on May 7, 2024 by MissionIR

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, today announced that it has published an article entitled: “Sigyn Therapy(TM), an Emerging Candidate to Address Endotoxemia, Sepsis and Drug-Resistant Viral & Bacterial Infections.” “When we designed Sigyn Therapy, we envisioned … Continue reading →

Posted in Sigyn Therapeutics Inc. SIGY | Leave a comment

SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) Soft Bait – New York’s Answer to the Growing Rat Problem

Posted on May 7, 2024 by MissionIR

On Thursday, April 11, Flaco, an escaped zoo owl, was found dead with raised levels of rodenticide in his system in New York City, having consumed poisoned rats for sustenance. This was a wake-up call, highlighting the ineffectiveness of the … Continue reading →

Posted in SenesTech Inc. SNES | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting the Massive Type 2 Diabetes and Obesity Markets with its DehydraTECH(TM) Technology

Posted on May 7, 2024 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recognizes the tremendous potential in the treatment of type 2 diabetes and obesity, and looks to address it through its patented DehydraTECH(TM) drug delivery technology that offers improved delivery … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

SuperCom Ltd. (NASDAQ: SPCB) Preparing to Deliver on $5 Million in New Sales Orders for European Electronic Monitoring Officials

Posted on May 7, 2024 by MissionIR

A series of new orders for electronic monitoring technology to bolster European governments’ security infrastructure is strengthening the position of SuperCom (NASDAQ: SPCB) in the EM market. The recent sales orders for SuperCom’s PureSecurity Suite of products amount to more than $5 … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Nasdaq Delisting Notification and Appeal, ADS Ratio Change

Posted on May 6, 2024 by MissionIR

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company today announced that it has received a staff determination letter on … Continue reading →

Posted in Scinai Immunotherapeutics Ltd. SCNI | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs

Posted on May 6, 2024 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, related to its mode of action and … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

Fentanyl Scourge: Nutriband Inc.’s (NASDAQ: NTRB) New Transdermal Patch with Abuse-Deterrent Tech Funded to Seek FDA Approval

Posted on May 6, 2024 by MissionIR

Fentanyl addiction continues to devastate communities, with current treatment options facing limitations. However, as often happens in healthcare, innovation breeds hope with a new option on the horizon planning to seek FDA marketing approval. The challenges related to the powerful … Continue reading →

Posted in Nutriband Inc. NTRB | Leave a comment

SenesTech Inc. (NASDAQ: SNES) Addressing the Growing Urban Rat Population, and Associated Disease Risks, with Unique EPA-Approved Rat Contraceptives

Posted on May 3, 2024 by MissionIR

SenesTech (NASDAQ: SNES), the inventor of the only EPA-registered contraceptive for male and female rats, recognizes the risks associated with growing rodent populations, especially in cities and areas with a substantial human population. Following its years of experience in the … Continue reading →

Posted in SenesTech Inc. SNES | Leave a comment

MissionIRNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q1 2024 Financial Results, Earnings Conference Call/Webcast

Posted on May 2, 2024 by MissionIR

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, will be releasing its first-quarter 2024 financial results this month. The company … Continue reading →

Posted in Longeveron Inc. LGVN | Leave a comment

MissionIRNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Announces Launch of Evolve(TM) Mouse to Control Mouse Infestations

Posted on May 2, 2024 by MissionIR

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced the launch of Evolve(TM) Mouse. Evolve Mouse utilizes a breakthrough fertility solution to control mouse infestations. It is designated as a ‘minimum’ risk product by … Continue reading →

Posted in SenesTech Inc. SNES | Leave a comment